Cargando…

A Case of Definitive Therapy for Localised Prostate Cancer: Report of a Urological Nightmare

Radical prostatectomy, external beam radiotherapy and permanent brachytherapy are the most common treatment options for nonmetastatic localised adenocarcinoma of the prostate (PCa). Accurate pretherapeutic clinical staging is difficult, the number of positive cores after biopsy does not imperatively...

Descripción completa

Detalles Bibliográficos
Autores principales: Sommerhuber, Andreas, Traxlmayr, Verena, Loidl, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175417/
https://www.ncbi.nlm.nih.gov/pubmed/21941535
http://dx.doi.org/10.1155/2012/632419
_version_ 1782212150536699904
author Sommerhuber, Andreas
Traxlmayr, Verena
Loidl, Wolfgang
author_facet Sommerhuber, Andreas
Traxlmayr, Verena
Loidl, Wolfgang
author_sort Sommerhuber, Andreas
collection PubMed
description Radical prostatectomy, external beam radiotherapy and permanent brachytherapy are the most common treatment options for nonmetastatic localised adenocarcinoma of the prostate (PCa). Accurate pretherapeutic clinical staging is difficult, the number of positive cores after biopsy does not imperatively represent the extension of the cancer. Furthermore postoperative upgrading in Gleason score is frequently observed. Even in a localised setting a certain amount of patients with organ-confined PCa will develop biochemical progression. In case of a rise in PSA level after radiation the majority of patients will receive androgen deprivation therapy what must be considered as palliative. If local or systemic progressive disease is associated with evolving neuroendocrine differentiation hormonal manipulation is increasingly ineffective; radiotherapy and systemic chemotherapy with a platinum agent and etoposide are recommended. In case of local progression complications such as pelvic pain, gross haematuria, infravesical obstruction and rectal invasion with obstruction and consecutive ileus can possibly occur. In this situation palliative radical surgery is a therapy option especially in the absence of distant metastases. A case with local and later systemic progression after permanent brachytherapy is presented here.
format Online
Article
Text
id pubmed-3175417
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-31754172011-09-22 A Case of Definitive Therapy for Localised Prostate Cancer: Report of a Urological Nightmare Sommerhuber, Andreas Traxlmayr, Verena Loidl, Wolfgang Adv Urol Clinical Study Radical prostatectomy, external beam radiotherapy and permanent brachytherapy are the most common treatment options for nonmetastatic localised adenocarcinoma of the prostate (PCa). Accurate pretherapeutic clinical staging is difficult, the number of positive cores after biopsy does not imperatively represent the extension of the cancer. Furthermore postoperative upgrading in Gleason score is frequently observed. Even in a localised setting a certain amount of patients with organ-confined PCa will develop biochemical progression. In case of a rise in PSA level after radiation the majority of patients will receive androgen deprivation therapy what must be considered as palliative. If local or systemic progressive disease is associated with evolving neuroendocrine differentiation hormonal manipulation is increasingly ineffective; radiotherapy and systemic chemotherapy with a platinum agent and etoposide are recommended. In case of local progression complications such as pelvic pain, gross haematuria, infravesical obstruction and rectal invasion with obstruction and consecutive ileus can possibly occur. In this situation palliative radical surgery is a therapy option especially in the absence of distant metastases. A case with local and later systemic progression after permanent brachytherapy is presented here. Hindawi Publishing Corporation 2012 2011-09-15 /pmc/articles/PMC3175417/ /pubmed/21941535 http://dx.doi.org/10.1155/2012/632419 Text en Copyright © 2012 Andreas Sommerhuber et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Sommerhuber, Andreas
Traxlmayr, Verena
Loidl, Wolfgang
A Case of Definitive Therapy for Localised Prostate Cancer: Report of a Urological Nightmare
title A Case of Definitive Therapy for Localised Prostate Cancer: Report of a Urological Nightmare
title_full A Case of Definitive Therapy for Localised Prostate Cancer: Report of a Urological Nightmare
title_fullStr A Case of Definitive Therapy for Localised Prostate Cancer: Report of a Urological Nightmare
title_full_unstemmed A Case of Definitive Therapy for Localised Prostate Cancer: Report of a Urological Nightmare
title_short A Case of Definitive Therapy for Localised Prostate Cancer: Report of a Urological Nightmare
title_sort case of definitive therapy for localised prostate cancer: report of a urological nightmare
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3175417/
https://www.ncbi.nlm.nih.gov/pubmed/21941535
http://dx.doi.org/10.1155/2012/632419
work_keys_str_mv AT sommerhuberandreas acaseofdefinitivetherapyforlocalisedprostatecancerreportofaurologicalnightmare
AT traxlmayrverena acaseofdefinitivetherapyforlocalisedprostatecancerreportofaurologicalnightmare
AT loidlwolfgang acaseofdefinitivetherapyforlocalisedprostatecancerreportofaurologicalnightmare
AT sommerhuberandreas caseofdefinitivetherapyforlocalisedprostatecancerreportofaurologicalnightmare
AT traxlmayrverena caseofdefinitivetherapyforlocalisedprostatecancerreportofaurologicalnightmare
AT loidlwolfgang caseofdefinitivetherapyforlocalisedprostatecancerreportofaurologicalnightmare